• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Stemline Therapeutics, Inc. (STML)

    -NasdaqCM
    14.47 Down 0.61(4.05%) 4:00PM EDT
    |After Hours : 14.47 0.00 (0.00%) 4:36PM EDT
    Add to Portfolio
    Prev Close:15.08
    Open:15.05
    Bid:13.60 x 100
    Ask:18.00 x 200
    1y Target Est:46.80
    Beta:-2.21
    Next Earnings Date:N/A
    Day's Range:14.46 - 15.13
    52wk Range:10.50 - 21.28
    Volume:99,937
    Avg Vol (3m):209,662
    Market Cap:188.12M
    P/E (ttm):N/A
    EPS (ttm):-2.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for STML

    Comparison

    Symbol% ChgMkt Cap
    STMLDown 4.05%188.12M
    OMEDDown 0.08%771.88M
    VSTMDown 3.05%365.66M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):584.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.93
    Quarterly EPS Est (Mar-15) :-0.45
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback